Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparative, Randomized, Two-Period, Crossover Study to Compare Pharmacokinetic Properties of ARN-75039 Tablets With Excipients to Neat ARN-75039 in Hydroxypropyl Methylcellulose (HPMC) Capsules in Healthy Adult Participants Under Fed Conditions

NCT06911242 is registered in ClinicalTrials.gov with Arisan Therapeutics, Inc. as lead sponsor.

NCT NCT06911242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06911242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparative, Randomized, Two-Period, Crossover Study to Compare Pharmacokinetic Properties of ARN-75039 Tablets With Excipients to Neat ARN-75039 in Hydroxypropyl Methylcellulose (HPMC) Capsules in Healthy Adult Participants Under Fed Conditions
Lead sponsor
Arisan Therapeutics, Inc.
Phase
Phase 1
Overall status
Completed
Start date
February 27, 2025
Completion date
April 21, 2025
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteer, pharmacokinetics after oral intake